Showing results (251-260 of 365) with videos related to
Sort By:
Pageof 37
Immunotargets and Therapy|December 25, 2023
Extended-Release Tofacitinib Therapy for a MDA5 Antibody-Positive Amyopathic Dermatomyositis Patient with Early-Stage Interstitial Lung DiseaseChrong-Reen Wang, Wei-Chieh Lin, Tak-Wah WongImmunotargets and Therapy|July 3, 2026
Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine ModelJunpeng Ma, Mingkun Wang, Kunnan Wang, et al.Immunotargets and Therapy|July 22, 2026
Near Infrared Photoimmunotherapy for Lung Cancer: Recent Development and PerspectiveRyu Okada, Mizuki Yamada, Mitsuo Sato, et al.Immunotargets and Therapy|September 3, 2026
Distinct Clinical and Prognostic Features of Acute and Chronic Active Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adults: A Scoping ReviewTiankuo Gao, Chun Yang, Yingxin Zhu, et al.Immunotargets and Therapy|September 5, 2026
Newcastle Disease Virus - Induced Interferons Regulate PD-L1 and MICA Expression in Human Tumor and Normal CellsTeridah Ernala Ginting, Young Othiwi Larasati, Vina Cornelia, et al.Immunotargets and Therapy|July 30, 2016
Immunotherapy in the management of melanoma: current statusDylan Alston, Jerry D BrewerImmunotargets and Therapy|July 30, 2016
Update on immunopathogenesis and immunotherapy in multiple sclerosisRebecca C Selter, Bernhard HemmerImmunotargets and Therapy|July 30, 2016
Update on the challenges and recent advances in cancer immunotherapyGianfranco Baronzio, Gurdev Parmar, Irina Zh Shubina, et al.Immunotargets and Therapy|July 30, 2016
T cell immunoglobulin domain and mucin domain-3 as an emerging target for immunotherapy in cancer managementAkihiro Yoneda, Masahisa JinushiImmunotargets and Therapy|July 30, 2016
Implications of chemokine receptors and inflammatory lipids in cancerJohannes Rolin, Azzam A MaghazachiPageof 37